The emerging practice of combining kratom, a legal botanical, with pain reliever – often referred to as "Kratom Lean" – presents a challenging legal grey area. For now, the federally regulated status of kratom remains in flux, varying considerably by state among localities, while codeine’s controlled nature adds another layer of regulatory un… Read More

Research chemicals, often known as "novel psychoactive drugs," present a complex challenge due to their evolving nature. These products are typically created for laboratory exploration, but are often encountered in the party drug market. The lack of extensive information on their possible effects means users face significant physical risks, whic… Read More

A alarming mix is emerging among individuals: the simultaneous ingestion of legal lean syrup – often containing DXM – and kratom, a leafy plant. This hazardous alliance presents grave medical threats. Both substances on their own carry substantial risk, but their interaction can worsen negative effects such as respiratory failure, cardiac com… Read More